Table 2 Endoscopic findings and clinical outcomes.

From: Timing of endoscopy in patients with upper gastrointestinal bleeding

 

Total (N = 572)

Urgent (n = 490)

Elective (n = 82)

P value

Diagnosis

0.569

Peptic ulcer

310 (54.2)

260 (53.1)

50 (61.0)

 

Malignancy

31 (5.4)

27 (5.5)

4 (4.9)

 

Mallory-Weiss syndrome

49 (8.6)

46 (9.4)

3 (3.7)

 

Gastroesophageal varix

142 (24.8)

124 (25.3)

18 (22.0)

 

Othersa

40 (7.0)

33 (6.7)

7 (8.5)

 

Endoscopic treatment

338 (59.1)

297 (60.0)

41 (50.0)

0.089

Thermocoagulation

170 (29.7)

147 (30.0)

23 (28.0)

 

Hemoclip

22 (3.8)

21 (4.3)

1 (1.2)

 

Injection

31 (5.4)

29 (5.9)

2 (2.4)

 

Band ligation

139 (24.3)

122 (24.9)

17 (20.7)

 

Combination

42 (7.3)

37 (7.6)

5 (6.1)

 

Embolization

3 (0.5)

3 (0.6)

0

1.000

RBC transfusion, unit

2 (0–16)

2 (0–16)

2 (0–8)

0.346

Rebleeding (n = 571)

34 (6.0)

29 (5.9)

5 (6.1)

1.000

Mortality

31 (5.4)

26 (5.3)

5 (6.1)

0.791

Hospital stay, days

6 (1–128)

6 (1–128)

6 (1–86)

0.401

  1. aOthers include marginal ulcer, acute gastric mucosal lesion, angioectasia, tuberculosis, esophageal ulcer, jejunal ulcer, gastrointestinal stromal tumor, and neuroendocrine tumor.